Advanced in AIDS Dysmorphic Syndrome

Dr. Susan L. Koletar

Infectious Disease
Osu Internal Medicine LLC
1581 Dodd Dr, Rm 491, 
Columbus, OH 
Accepting New Patients
Advanced in AIDS Dysmorphic Syndrome
Osu Internal Medicine LLC
1581 Dodd Dr, Rm 491, 
Columbus, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Susan Koletar is an Infectious Disease provider in Columbus, Ohio. Dr. Koletar is rated as an Advanced provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. Her top areas of expertise are HIV/AIDS, AIDS Dementia Complex, Myelitis, and AIDS Dysmorphic Syndrome. Dr. Koletar is currently accepting new patients.

Her clinical research consists of co-authoring 67 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Infectious Disease
Licenses
Internal Medicine in OH
Hospital Affiliations
Ohio State University State Health System
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

OSU INTERNAL MEDICINE LLC
1581 Dodd Dr, Rm 491, Columbus, OH 43210
Other Locations
OSU INTERNAL MEDICINE LLC
3900 Stoneridge Ln, Dublin, OH 43017

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses
Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses
Enrollment Status: Completed
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Elvitegravir+Cobicistat+Emtricitabine+Tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
Study Phase: Phase 2
Safety, Tolerability and Immunogenicity of Recombinant HIV Envelope Protein VRC-HIVRGP096-00-VP (Trimer 4571) Vaccine, in HIV-1 Infected Adults on Suppressive ART
Safety, Tolerability and Immunogenicity of Recombinant HIV Envelope Protein VRC-HIVRGP096-00-VP (Trimer 4571) Vaccine, in HIV-1 Infected Adults on Suppressive ART
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2025
Intervention Type: Biological
Study Drug: Trimer 4571 vaccine
Study Phase: Phase 1
A Phase I Study to Evaluate the Safety, Tolerability and Immunogenicity of a Therapeutic HIV Vaccine Composed of Autologous Dendritic Cells Loaded With Autologous Inactivated Whole Virus or Conserved Peptides in ART-treated HIV-infected Adults
A Phase I Study to Evaluate the Safety, Tolerability and Immunogenicity of a Therapeutic HIV Vaccine Composed of Autologous Dendritic Cells Loaded With Autologous Inactivated Whole Virus or Conserved Peptides in ART-treated HIV-infected Adults
Enrollment Status: Completed
Publish Date: February 24, 2025
Intervention Type: Biological
Study Drugs: a1DC + inactivated whole autologous HIV, a1DC + conserved HIV peptides, a1DC + no antigen, pgDC + inactivated whole autologous HIV, pgDC + conserved HIV peptides, pgDC + no antigena1DC
Study Phase: Phase 1
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
Enrollment Status: Completed
Publish Date: October 28, 2024
Intervention Type: Drug
Study Phase: Phase 3
An International Observational Study to Characterize Adults Who Are Hospitalized With Influenza or Other Targeted Respiratory Viruses
An International Observational Study to Characterize Adults Who Are Hospitalized With Influenza or Other Targeted Respiratory Viruses
Enrollment Status: Completed
Publish Date: October 21, 2024
A Single-arm Study to Evaluate the Feasibility and Efficacy of a Minimal Monitoring Strategy to Deliver Pan-genotypic Ribavirin-free HCV Therapy to HCV Infected Populations Who Are HCV Treatment Naïve With Evidence of Active HCV Infection: The MINMON Study
A Single-arm Study to Evaluate the Feasibility and Efficacy of a Minimal Monitoring Strategy to Deliver Pan-genotypic Ribavirin-free HCV Therapy to HCV Infected Populations Who Are HCV Treatment Naïve With Evidence of Active HCV Infection: The MINMON Study
Enrollment Status: Completed
Publish Date: February 04, 2022
Intervention Type: Drug, Other
Study Phase: Phase 4
Safety, Tolerability, and Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome and Immune Activation Markers in HIV-Infected Participants on Suppressive Antiretroviral Therapy: A Phase II Study
Safety, Tolerability, and Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome and Immune Activation Markers in HIV-Infected Participants on Suppressive Antiretroviral Therapy: A Phase II Study
Enrollment Status: Completed
Publish Date: January 06, 2020
Intervention Type: Drug
Study Phase: Phase 2
Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure (ASPIRE) Study
Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure (ASPIRE) Study
Enrollment Status: Completed
Publish Date: October 14, 2019
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blinded, Placebo-Controlled Trial of a Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin, Januvia) for Reducing Inflammation and Immune Activation in HIV-Infected Men and Women: A Multicenter Trial of the AIDS Clinical Trials Group (ACTG)
A Randomized, Double-Blinded, Placebo-Controlled Trial of a Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin, Januvia) for Reducing Inflammation and Immune Activation in HIV-Infected Men and Women: A Multicenter Trial of the AIDS Clinical Trials Group (ACTG)
Enrollment Status: Completed
Publish Date: June 18, 2018
Intervention Type: Drug
Study Phase: Phase 2
A Study to Evaluate Dolutegravir Plus Lamivudine Dual Therapy for the Treatment of Naïve HIV-1-infected Participants
A Study to Evaluate Dolutegravir Plus Lamivudine Dual Therapy for the Treatment of Naïve HIV-1-infected Participants
Enrollment Status: Completed
Publish Date: May 09, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

67 Total Publications

Physical Activity, Cigarette Smoking, and Depression Among People with HIV.
Physical Activity, Cigarette Smoking, and Depression Among People with HIV.
Journal: AIDS and behavior
Published: April 05, 2025
Similar Doctors
Distinguished in AIDS Dysmorphic Syndrome
Dr. Andrew R. Dagg-Murry
Infectious Disease
Distinguished in AIDS Dysmorphic Syndrome
Dr. Andrew R. Dagg-Murry
Infectious Disease

Fairfield Healthcare Professionals Inc

135 N Ewing St, Suite 302, 
Lancaster, OH 
 (30.4 miles away)
740-689-6430
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Dagg-Murry is an Infectious Disease provider in Lancaster, Ohio. Dr. Dagg-Murry is rated as an Advanced provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. His top areas of expertise are Myelitis, HIV/AIDS, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Dagg-Murry is currently accepting new patients.

Michael F. Para
Advanced in AIDS Dysmorphic Syndrome
Dr. Michael F. Para
Infectious Disease
Advanced in AIDS Dysmorphic Syndrome
Dr. Michael F. Para
Infectious Disease
456 W 10th Ave, 
Columbus, OH 
 (0.1 miles away)
614-947-3700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Para is an Infectious Disease provider in Columbus, Ohio. Dr. Para is rated as an Advanced provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Para is currently accepting new patients.

Advanced in AIDS Dysmorphic Syndrome
Dr. David A. Wininger
Infectious Disease
Advanced in AIDS Dysmorphic Syndrome
Dr. David A. Wininger
Infectious Disease

Osu Internal Medicine LLC

1581 Dodd Dr, Rm 491, 
Columbus, OH 
 (0.1 miles away)
614-293-3800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Wininger is an Infectious Disease provider in Columbus, Ohio. Dr. Wininger is rated as an Advanced provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. His top areas of expertise are Myelitis, AIDS Dementia Complex, HIV/AIDS, and AIDS Dysmorphic Syndrome. Dr. Wininger is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Koletar's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile